A concise, up-to-date review of the many new therapies available for the treatment of benign prostatic hypertrophy (BPH). The authors concisely evaluate the latest minimally invasive therapies, as well as time-tested surgical treatments, and review the medical therapies for BPH, namely a-adrenergic antagonists, 5-a reductase inhibitors, and their therapeutic combinations. Additional chapters examine the pathophysiology and natural history of BPH, its epidemiology, and the urodynamic evaluation of lower urinary tract symptoms. A perfect reference source for the practicing urologist seeking sound guidance on the best approach to his patients.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
"This is a high quality, comprehensive review of BPH management. The book covers the major aspects of managing a patient with BPH including a thorough discussion of pathophysiology, diagnostic evaluation, and medical/surgical/procedural intervention. The evaluation and pathophysiology chapters are handled quite well as are the minimally invasive therapies. This type of review, particularly if followed by updated editions, would greatly assist practicing urologists in providing a practical review of the topic and in staying on the cutting edge in treating patients with BPH. "-Doody's Health Sciences Book Review Journal